CYTOSORBENTS CORPORATION Liabilities, Noncurrent
CYTOSORBENTS CORPORATION (CTSO) had Liabilities, Noncurrent of $0 as of 2012-09-30, per its 10-Q filed 2012-11-21.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:LiabilitiesNoncurrent · last filed 2013-04-03
- 2012-09-30: Liabilities, Noncurrent $0.00.
- 2011-12-31: Liabilities, Noncurrent $276.25K.
- 2011-09-30: Liabilities, Noncurrent $224.82K.
- 2011-06-30: Liabilities, Noncurrent $526.55K.
| Period end | Liabilities, Noncurrent |
|---|---|
| 2012-09-30 | $0.00 10-Q · filed 2012-11-21 |
| 2011-12-31 | $276.25K 10-K · filed 2013-04-03 |
| 2011-09-30 | $224.82K 10-Q · filed 2011-11-14 |
| 2011-06-30 | $526.55K 10-Q · filed 2011-08-15 |
| 2010-12-31 | $1.08M 10-K · filed 2012-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |